Clinical trial
Homoeriodictyol Sodium Mouthwash to Reduce Chemotherapy Induced Bitter Taste Disorders - a Pilot Study
NCT07573787 is registered in ClinicalTrials.gov with Christoph Grimm as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Homoeriodictyol Sodium Mouthwash to Reduce Chemotherapy Induced Bitter Taste Disorders - a Pilot Study
- Lead sponsor
- Christoph Grimm
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- March 15, 2021
- Completion date
- January 11, 2023
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gynecologic cancers